Cocrystal Pharma (COCP) News Today $2.06 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period COCP: Multiple Upcoming Catalysts…November 19 at 2:52 PM | msn.comCocrystal Pharma Reports Financial Results and Updates on Antiviral Drug-Development ProgramsOn November 13, 2024, Cocrystal Pharma, Inc. (NASDAQ: COCP) provided an overview of its financial results for the third quarter of 2024 and delivered updatesNovember 19 at 2:17 AM | americanbankingnews.comNovember 2024 US Exchange Standouts: Promising Penny StocksNovember 16, 2024 | nz.finance.yahoo.comCocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsNovember 13, 2024 | finance.yahoo.comHere's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn SituationOctober 18, 2024 | finance.yahoo.comCocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose CohortsSeptember 26, 2024 | finance.yahoo.comBuy Rating Affirmed for Cocrystal Pharma Amid Promising Drug Pipeline and Strong Clinical ResultsAugust 22, 2024 | markets.businessinsider.comCOCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…August 19, 2024 | msn.comCocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment ConferencesAugust 19, 2024 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS)August 15, 2024 | markets.businessinsider.comCocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsAugust 14, 2024 | stockhouse.comCocrystal Pharma Gets Positive Result From Phase 1 Study With CDI-988; Stock UpJuly 19, 2024 | markets.businessinsider.comCOCP: Phase 1 Single-Ascending Dose Cohort of CDI-988 Shows it is Safe and Well Tolerated…July 19, 2024 | msn.comCOCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…May 16, 2024 | finance.yahoo.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024May 13, 2024 | investorplace.comCocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMay 13, 2024 | globenewswire.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | finance.yahoo.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | globenewswire.comCOCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…April 23, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and Icecure Medical (ICCM)April 5, 2024 | markets.businessinsider.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023March 28, 2024 | msn.comCocrystal Pharma, Inc.: Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 28, 2024 | finanznachrichten.deRecap: Cocrystal Pharma Q4 EarningsMarch 28, 2024 | benzinga.comCocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 28, 2024 | globenewswire.comCocrystal Pharma, Inc.: Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AMarch 20, 2024 | finanznachrichten.deCocrystal Pharma Receives Pre-IND Feedback Regarding CC-42344 - Quick FactsMarch 19, 2024 | markets.businessinsider.comCocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AMarch 19, 2024 | globenewswire.comCocrystal Pharma Inc (COCP)February 24, 2024 | investing.comCOCP: Cocrystal Pharma provides updates on its clinical programs.February 20, 2024 | finance.yahoo.comCocrystal Pharma Inc COCPFebruary 11, 2024 | morningstar.comCocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational CandidatesJanuary 4, 2024 | finance.yahoo.comCocrystal Pharma Stock (NASDAQ:COCP), Analyst Ratings, Price Targets, PredictionsDecember 26, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP) Dividends: History, Yield and DatesDecember 26, 2023 | benzinga.comCocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza ADecember 6, 2023 | finance.yahoo.comCocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 29, 2023 | finance.yahoo.comCocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023November 27, 2023 | finance.yahoo.comCocrystal Pharma Stock (NASDAQ:COCP) Earnings Dates and Earning CallsNovember 14, 2023 | benzinga.comCOCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.November 14, 2023 | msn.comRecap: Cocrystal Pharma Q3 EarningsNovember 13, 2023 | benzinga.comCocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsNovember 13, 2023 | finance.yahoo.comCocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 9, 2023 | finance.yahoo.comBuy Rating Issued for Cocrystal Pharma Amid Advancements in Influenza and Coronavirus TreatmentsNovember 3, 2023 | markets.businessinsider.comCocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344October 31, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Cocrystal Pharma (COCP) Buy RecommendationOctober 5, 2023 | msn.comCOCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial.October 2, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline.August 16, 2023 | finance.yahoo.comAnalyst Ratings for Cocrystal PharmaAugust 15, 2023 | markets.businessinsider.comCocrystal Pharma (COCP) Receives a Buy from H.C. WainwrightAugust 15, 2023 | markets.businessinsider.comNoble Financial Keeps Their Buy Rating on Cocrystal Pharma (COCP)August 15, 2023 | markets.businessinsider.comCocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsAugust 14, 2023 | finance.yahoo.com Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW COCP Media Mentions By Week COCP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COCP News Sentiment▼0.760.45▲Average Medical News Sentiment COCP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COCP Articles This Week▼40▲COCP Articles Average Week Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CASI News Today IKNA News Today PMVP News Today QNCX News Today IMAB News Today CLSD News Today CMRX News Today FBLG News Today ME News Today ONCY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COCP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COCP Stock Alerts